Streetbeat News

Stock Prices

GME

GameStop shares experienced a spike in trading volume and turned positive, indicating increased investor interest and potential short-term price movement.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 3:15 pm

BB

BlackBerry's shares are trading lower following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 3:11 pm

BMY

Bristol Myers Squibb announced positive results from the Phase 3b/4 PSORIATYK SCALP trial, demonstrating the efficacy of Sotyktu in treating moderate-to-severe scalp psoriasis. The trial showed Sotyktu's superiority over placebo in all primary and secondary endpoints at Week 16, with significant symptom improvement. The safety profile was consistent with previous studies.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 3:11 pm

BIDU

FXI

KWEB

Baidu Inc (NASDAQ:BIDU) shares surged 22% this week due to favorable macroeconomic developments in China, including the People's Bank of China's aggressive monetary easing measures. These measures, such as cutting the reserve requirement ratio and repo rates, are expected to benefit Baidu by increasing liquidity and capital access, aiding its growth in AI and other tech sectors. Baidu is also set to gain from potential fiscal stimulus plans in China, which could boost infrastructure spending in areas like AI and autonomous driving.

Portfolio Pulse from Henry Khederian

September 27, 2024 | 3:08 pm

HYLN

Hyliion's shares rose following the announcement that its KARNO linear generator qualifies under California's renewables portfolio standard.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 3:07 pm

HOOD

Robinhood has been highlighted by Investors Business Daily as a new buy, which could influence investor interest and potentially impact its stock price.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 3:03 pm

CYTK

Cytokinetics presented new data from its SEQUOIA-HCM trial, showing that 83.8% of patients treated with aficamten experienced favorable effects compared to 39.3% on placebo. The trial demonstrated significant improvements in several cardiac health indices.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 3:02 pm

KALV

KaiVista Pharmaceuticals shares rose following Jones Trading's initiation of coverage with a Buy rating and a $35 price target.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 3:01 pm

LTCUSD

Litecoin (LTC) has seen a 4.5% price increase in the last 24 hours, continuing its positive trend with an 8% gain over the past week. Trading volume has increased by 18%, while circulating supply slightly decreased. LTC's market cap is ranked #25 at $5.27 billion.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 3:01 pm